These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19109693)

  • 1. Serum of patients with septic shock stimulates the expression of Trem-1 on U937 monocytes.
    Dimopoulou I; Orfanos SE; Pelekanou A; Kotanidou A; Livaditi O; Augustatou C; Zervou M; Douka E; Theodorakopoulou M; Karagianni V; Douzinas E; Armaganidis A; Giamarellos-Bourboulis EJ
    Inflamm Res; 2009 Mar; 58(3):127-32. PubMed ID: 19109693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression.
    Dimopoulou I; Pelekanou A; Mavrou I; Savva A; Tzanela M; Kotsaki A; Kardara M; Orfanos SE; Kotanidou A; Giamarellos-Bourboulis EJ
    J Crit Care; 2012 Jun; 27(3):294-300. PubMed ID: 21855288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?
    Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C
    Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocytes as a site of production of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in the septic host.
    Plachouras D; Routsi C; Giamarellos-Bourboulis EJ; Spyridaki E; Andrianakis I; Metzelopoulos S; Tsaganos T; Floros I; Douzinas EE; Armaganidis A; Roussos C; Giamarellou H
    Scand J Infect Dis; 2006; 38(10):909-15. PubMed ID: 17008237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
    J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex-vivo effect of dexamethasone on cytokine production from whole blood of septic patients: correlation with disease severity.
    Giamarellos-Bourboulis EJ; Dimopoulou I; Kotanidou A; Livaditi O; Pelekanou A; Tsagarakis S; Armaganidis A; Orfanos SE
    Cytokine; 2010 Jan; 49(1):89-94. PubMed ID: 19783455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS.
    Oku R; Oda S; Nakada TA; Sadahiro T; Nakamura M; Hirayama Y; Abe R; Tateishi Y; Ito M; Iseki T; Hirasawa H
    Cytokine; 2013 Jan; 61(1):112-7. PubMed ID: 23046618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis.
    Collins CE; La DT; Yang HT; Massin F; Gibot S; Faure G; Stohl W
    Ann Rheum Dis; 2009 Nov; 68(11):1768-74. PubMed ID: 19054829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
    Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
    Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased expression of TREM-1 on monocytes is associated with infectious and noninfectious inflammatory processes.
    Ferat-Osorio E; Esquivel-Callejas N; Wong-Baeza I; Aduna-Vicente R; Arriaga-Pizano L; Sánchez-Fernández P; Torres-González R; López-Macías C; Isibasi A
    J Surg Res; 2008 Nov; 150(1):110-7. PubMed ID: 18656898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 13 and inflammatory markers in human sepsis.
    Collighan N; Giannoudis PV; Kourgeraki O; Perry SL; Guillou PJ; Bellamy MC
    Br J Surg; 2004 Jun; 91(6):762-8. PubMed ID: 15164448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation.
    Bopp C; Hofer S; Bouchon A; Zimmermann JB; Martin E; Weigand MA
    Eur J Anaesthesiol; 2009 Jun; 26(6):504-7. PubMed ID: 19307971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion.
    Huang LY; Shi HZ; Liang QL; Wu YB; Qin XJ; Chen YQ
    Chin Med J (Engl); 2008 Sep; 121(17):1656-61. PubMed ID: 19024094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients.
    Wong-Baeza I; González-Roldán N; Ferat-Osorio E; Esquivel-Callejas N; Aduna-Vicente R; Arriaga-Pizano L; Astudillo-de la Vega H; Villasis-Keever MA; Torres-González R; Estrada-García I; López-Macías C; Isibasi A
    Clin Exp Immunol; 2006 Sep; 145(3):448-55. PubMed ID: 16907912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.
    Sundén-Cullberg J; Nyström T; Lee ML; Mullins GE; Tokics L; Andersson J; Norrby-Teglund A; Treutiger CJ
    Crit Care Med; 2007 Jun; 35(6):1536-42. PubMed ID: 17452927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis.
    Giamarellos-Bourboulis EJ; Zakynthinos S; Baziaka F; Papadomichelakis E; Virtzili S; Koutoukas P; Armaganidis A; Giamarellou H; Roussos C
    Intensive Care Med; 2006 Feb; 32(2):237-243. PubMed ID: 16450102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis.
    Marioli A; Koupetori M; Raftogiannis M; Patrani M; Antonakos N; Pavlaki M; Adamis G; Dougekou G; Damoraki G; Tsangaris I
    BMC Immunol; 2014 Dec; 15():585. PubMed ID: 25532536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis.
    Giamarellos-Bourboulis EJ; Tsaganos T; Spyridaki E; Mouktaroudi M; Plachouras D; Vaki I; Karagianni V; Antonopoulou A; Veloni V; Giamarellou H
    Crit Care; 2006; 10(6):R166. PubMed ID: 17129388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis.
    Yasuda T; Takeyama Y; Ueda T; Shinzeki M; Sawa H; Takahiro N; Kamei K; Ku Y; Kuroda Y; Ohyanagi H
    Crit Care Med; 2008 Jul; 36(7):2048-53. PubMed ID: 18552693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.